TITLE

Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay

AUTHOR(S)
da Fonseca, Luiz M; Brunetti, Iguatemy L; Campa, Ana; Catalani, Luiz H; Calado, Rodrigo T; Falcao, Roberto P
PUB. DATE
January 2003
SOURCE
Hematology Journal;2003, Vol. 4 Issue 1, p26
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
INTRODUCTION:: Classically, the monocytic component of acute myelomonocytic (FAB-M4) and acute monocytic/monoblastic (FAB-M5) leukemias is demonstrated by nonspecific esterase positivity in cytochemical stainings. We have previously demonstrated that non-specific esterases from normal monocytes can be determined by a chemiluminescent method. In the present study, we investigated whether this assay can also determine the monocytic component of FAB-M4 and FAB-M5 and distinguish these acute myeloid leukemia (AML) categories. MATERIALS AND METHODS:: Bone marrow samples were obtained from 66 patients with AML (M0, two cases; M1, 12 cases; M2, 13 cases; M3, 10 cases; M4, 11 cases; M5, 12 cases; M6, two cases; M7, four cases). Cells were incubated with a standard reaction mixture and chemiluminescence was measured for 10?min. Two parameters were assessed, the peak (PLE) and the integrated light emission (ILE). RESULTS:: Both PLE and ILE were higher in FAB-M4 and FAB-M5 subtypes compared to other AML subtypes (P<0.001). In addition, the classification of AML cases into FAB-M4, FAB-M5 and nonmonocytic subtypes based on ILE analysis was concordant with a-naphthyl acetate esterase (ANAE) in 97% of cases (kappa coefficient 0.94, P<0.001). CONCLUSIONS:: These findings indicate that this chemiluminescent assay was able to determine the monocytic component of FAB-M4 and FAB-M5 cells, and the classification of AML subtypes based on chemiluminescent analysis strongly agreed with the cytochemical ANAE-staining. In conclusion, this chemiluminescent assay is a simple, fast and objective method, which may be useful as an alternative tool in the differential diagnosis of AML subtypes.The Hematology Journal (2003) 4, 26-30. doi:10.1038/sj.thj.6200209
ACCESSION #
9514260

 

Related Articles

  • Prognostic significance of FLT3 ITD and D835 mutations in AML patients. Sheikhha, Mohammad Hasan; Awan, Abida; Tobal, Khalid; Liu Yin, John Ahman // Hematology Journal;2003, Vol. 4 Issue 1, p41 

    Both ITD and D835 mutations of the fms-like tyrosine kinase (FLT3) gene cause constitutive activation of the receptor, in the absence of ligand. We have examined a cohort of 91 patients, AML (80) and MDS (11), to determine the prevalence of these mutations and any correlations between the two...

  • IN BRIEF.  // Hem/Onc Today;12/25/2008, Vol. 9 Issue 23, p25 

    The article presents updates on hematology and oncology. According to a univariate analysis, there is a non-significant cost savings with enoxaparin venous thromboembolism (VTE) prophylaxis. According to a clinical trial, decitabine active in older patients with previously untreated acute...

  • Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China. Cheng, Y.; Wang, Y.; Wang, H.; Chen, Z.; Lou, J.; Xu, H.; Wand1,2, H.; Qian, W.; Meng, H.; Lin, M.; Jin, J. // Leukemia (08876924);Oct2009, Vol. 23 Issue 10, p1801 

    Geographic heterogeneity of cytogenetic patterns in hematological malignancies has been reported earlier, but few systematic studies of cytogenetic abnormalities in acute myeloid leukemia (AML) patients are available. We examined the karyotypic patterns in 1432 de novo AML patients from a single...

  • Invasive Coinfection with Aspergillus and Mucor in a Patient with Acute Myeloid Leukemia. Bergantim, Rui; Rios, Elisabete; Trigo, Fernanda; GuimarĂ£es, Jose // Clinical Drug Investigation;Feb2013 Supplement, Vol. 33, p51 

    The authors report the case of a 58-year-old female patient with a life-threatening invasive fungal disease caused by a coinfection of Aspergillus and Mucor species that occurred during induction and consolidation chemotherapy for an acute myeloid leukemia. The disease was successfully treated...

  • Hematology.  // Clinical & Investigative Medicine;Dec98 Supplement, Vol. 21, pS43 

    The article presents various studies related to hematology. These studies include the use of outpatient low molecular weight heparin in the treatment of deep vein thrombosis of the upper extremity, donor leukocyte infusion which induces long-term molecular remission and therapeutic leukapheresis...

  • Perspectives of gene expression profiling for diagnosis and therapy in haematological malignancies. Bacher, Ulrike; Kohlmann, Alexander; Haferlach, Torsten // Briefings in Functional Genomics & Proteomics;May2009, Vol. 8 Issue 3, p184 

    Considering the heterogeneity of leukaemias and the widening spectrum of therapeutic strategies, novel diagnostic methods are urgently needed for haematological malignancies. For a decade, gene expression profiling (GEP) has been applied in leukaemia research. Thus, various studies demonstrated...

  • XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis. Tamm, Ingo; Richter, Stephan; Scholz, Frank; Schmelz, Karin; Oltersdorf, Doreen; Karawajew, Leonid; Schoch, Claudia; Haferlach, Torsten; Ludwig, Wolf-Dieter; Wuchter, Christian // Hematology Journal;2004, Vol. 5 Issue 6, p489 

    Antiapoptotic proteins like the inhibitor of apoptosis proteins (IAPs) are molecular markers potentially useful for the characterization of acute myeloid leukemia (AML). We screened 92 adults with de novo AML for the protein expression of various IAPs, Bcl-2 family members and the proform of...

  • Proven invasive pulmonary mucormycosis successfully treated with amphotericin B and surgery in patient with acute myeloblastic leukemia: a case report. Vidovic, Ana; Arsic-Arsenijevic, Valentina; Tomin, Dragica; Djunic, Irena; Jakovic, Radoslav; Loncar, Zlatibor; Barac, Aleksandra // Journal of Medical Case Reports;2013, Vol. 7 Issue 1, p1 

    Introduction Invasive mucormycosis (zygomycosis) is the third most frequent fungal infection in patients with hematologic malignancies. It often results in a fatal outcome mainly due to the difficulty of early diagnosis and its resistance to antimycotics. Case presentation A 52-year-old...

  • CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Sellar, Rob // Current Medical Literature: Leukemia & Lymphoma;2013, Vol. 21 Issue 3, p92 

    The article discusses research which examined suggestions that early cytomegalovirus (CMV) reactivation after allogeneic transplantation protects against reactivation of hematological malignancies. It references a study by M. L. Green et al, published in a 2013 issue of the journal "Blood."...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics